Zhejiang Haisen Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 192.43 million compared to CNY 210.16 million a year ago. Revenue was CNY 193.37 million compared to CNY 211.34 million a year ago.

Net income was CNY 45.81 million compared to CNY 56.87 million a year ago. Basic earnings per share from continuing operations was CNY 0.81 compared to CNY 1.12 a year ago. Diluted earnings per share from continuing operations was CNY 0.81 compared to CNY 1.12 a year ago.